Latest Peplin news
09-June-09
Peplin Initiates Phase 3 Clinical Trials with PEP005 Gel in AK on Face and Scalp read more
28-May-09
Peplin's Positive Phase II AK Trial Results Published in JAAD read more
17-May-09
Positive Results for Peplin's First Phase III AK Trial read more
15-May-09
Peplin Results for the Quarter Ended 31 March 2009 read more
Peter Welburn PhD
General Manager, Australia
CSO & Vice President, Research & Development
Dr. Welburn has served as our Chief Scientific Officer and Vice President, Research & Development since April 2001 and as the General Manager, Australia of Peplin Limited since January 2007. Prior to joining Peplin Limited, from February 1991 to March 2001, Dr. Welburn was employed by SmithKline Beecham, a pharmaceutical and healthcare company, in its global strategic marketing group. Before moving to SmithKline Beecham in 1991, Dr. Welburn managed both Australian and international research and development programs for a number of compounds at Janssen Pharmaceuticals, a pharmaceutical company.
Dr. Welburn received a Ph.D. from Cardiff University.
Executive Management
- Thomas Wiggans, Chairman and Chief Executive Officer
- Eugene Bauer MD, President and Chief Medical Officer
- Cheri Jones, Vice President, Regulatory Affairs
- George Mahaffey, Chief Commercial Officer & Vice President, Sales & Marketing
- David Smith, Chief Financial Officer
- Peter Welburn PhD, General Manager, Australia, CSO & Vice President, Research & Development